NCT03159845View on ClinicalTrials.gov

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

September 10, 2019

Study Completion Date

September 10, 2019

Conditions
Stem Cell Transplant Complications
Interventions
DRUG

Zinc Sulfate Oral Product

DRUG

Levofloxacin 500Mg Oral Tablet

once daily from day +10 until day +30 after stem cell transplantation

DRUG

Fluconazole 200mg tab

twice daily from day +10 until day +30 after stem cell transplantation

DRUG

Acyclovir 400 MG

twice daily from day +10 until day +30 after stem cell transplantation

Trial Locations (1)

56126

Hematology UO, Pisa

All Listed Sponsors
lead

Azienda Ospedaliero, Universitaria Pisana

OTHER

NCT03159845 - Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies | Biotech Hunter | Biotech Hunter